New bladder treatment aims to stop Cancer's return, spare patients major surgery
Disease control
Not yet recruiting
This Phase 3 study is testing a new drug called NDV-01 for people with non-muscle invasive bladder cancer (NMIBC). It aims to see if putting the drug directly into the bladder can prevent the cancer from coming back and stop it from getting worse, which could help patients avoid …
Phase: PHASE3 • Sponsor: Relmada Therapeutics, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC